Skip to main content

Fighting COVID-19

Services

Print this Article

Related Content

CARE Consortium
IMI2–Call 21
COVID-19

CARE Consortium

CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.
Read more
COVID-19: Research Update
COVID-19: Phase 2 Clinical Trial
COVID-19

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19
Read more
Global Access Commitment with Gates Foundation
COVID-19_Joint-bmgf-global-access-communique (2)
COVID-19

Global Access Commitment with Gates Foundation

Boehringer Ingelheim commits to provide global access to COVID-19 therapeutics by signing communiqué with the Gates Foundation.
Read more